Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.57 |
| ▸ | MAPT | P10636 | 4/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | GSK3B | P49841 | 1/20 | 0.43 |
| ▸ | HASPIN | Q8TF76 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29618079 | 1.00 | ALDH1A1 (0.57) | ALDH1A1MAPTTDP1MEN1KMT2A | |
| Methane SCHEMBL28322282 | 0.98 | ALDH1A1 (0.55) | ALDH1A1MAPTTDP1MEN1KMT2A | |
| SCHEMBL1284068 | 0.83 | MAPT (0.53) | ALDH1A1MAPTTDP1MEN1KMT2A | |
| Ethoxycarbonyl Group SCHEMBL28109244 | 0.82 | MAPT (0.43) | ALDH1A1MAPTTDP1MEN1KMT2A | |
| SCHEMBL2219710 | 0.81 | ALDH1A1 (0.48) | ALDH1A1MAPTTDP1MEN1KMT2A | |
| SCHEMBL8568179 | 0.80 | ALDH1A1 (0.53) | ALDH1A1MAPTMEN1KMT2APOLB | |
| Ethylene SCHEMBL27749127 | 0.77 | ALDH1A1 (0.50) | ALDH1A1MAPTMEN1KMT2APOLB | |
| SCHEMBL3577339 | 0.76 | MAPT (0.52) | ALDH1A1MAPTTDP1MEN1KMT2A | |
| SCHEMBL319309 | 0.75 | ALDH1A1 (0.49) | ALDH1A1MAPTMEN1KMT2APOLB | |
| SCHEMBL227454 | 0.75 | ALDH1A1 (0.49) | ALDH1A1MAPTTDP1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 509 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117924347-A | Preparation method of monosulfur organosilane coupling agent | 江西宏柏新材料股份有限公司 | 2024-04-26 | — | — | CN | claimed |
| CN-115184486-B | Method for detecting diaminopyridine phosphate related substances by high performance liquid chromatography | 河北一品生物医药有限公司 | 2023-07-18 | — | — | CN | claimed |
| CN-114682102-B | Reverse osmosis membrane and preparation method thereof | 沃顿科技股份有限公司 | 2023-06-27 | — | — | CN | claimed |
| CN-114432900-B | Preparation method of anti-pollution composite reverse osmosis membrane and anti-pollution composite reverse osmosis membrane prepared by same | 沃顿科技股份有限公司 | 2023-03-21 | — | — | CN | claimed |
| CN-115184486-A | Method for detecting related substances of diaminopyridine phosphate by high performance liquid chromatography | 河北一品生物医药有限公司 | 2022-10-14 | — | — | CN | claimed |
| CN-114682102-A | Reverse osmosis membrane and preparation method thereof | 沃顿科技股份有限公司 | 2022-07-01 | — | — | CN | claimed |
| CN-114432900-A | Preparation method of anti-pollution composite reverse osmosis membrane and anti-pollution composite reverse osmosis membrane prepared by same | 沃顿科技股份有限公司 | 2022-05-06 | — | — | CN | claimed |
| CN-114315706-A | Synthetic method of 3, 4-diaminopyridine | 河北一品生物医药有限公司 | 2022-04-12 | — | — | CN | claimed |
| CN-103342621-B | Method for performing catalytic synthesis of diphenylamine derivatives by using bisphenol copper salt | HEILONGJIANG UNIVERSITY (CN) | 2014-10-29 | — | — | CN | claimed |
| CN-103342621-A | Method for performing catalytic synthesis of diphenylamine derivatives by using bisphenol copper salt | UNIV HEILONGJIANG | 2013-10-09 | — | — | CN | claimed |
| CN-101343366-A | Nano-laminal compound with regular array of pyridine and its derivant, and preparation thereof | UNIV SHANGHAI (CN) | 2009-01-14 | — | — | CN | claimed |
| CN-1660842-A | Preparation of 4-hydroxy-3-nitro-2(1h)-pyridone from 2-hydroxy-3-cyano-4-methoxypyridine | AVENTIS PHARMA INC (US) | 2005-08-31 | — | — | CN | claimed |
| CN-1394859-A | Intermediate for preparing cyclopentane formamide compound and preparation method thereof | AVENTIS PHARMACEUTICAL CO (US) | 2003-02-05 | — | — | CN | claimed |
| CN-1240445-A | Preparation method of [ 1S- [1a,2b,3b,4a ] ] -4- [ 7- [ [ 1- (3-chloro-2-thienyl) methyl ] propyl ] amino-3H-imidazo [4, 5-b ] pyridin-3-yl ] -N-ethyl-2, 3-dihydroxycyclopentanecarboxamide | RHONE POULENC RORER PHARMA (US) | 2000-01-05 | — | — | CN | claimed |
| US-20260116878-A1 | INDAZOLE INHIBITORS OF THE WNT SIGNAL PATHWAY AND THERAPEUTIC USES THEREOF | BIOSPLICE THERAPEUTICS INC (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4689155-A1 | USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS | Astrazeneca AB (SE) | 2026-02-11 | — | — | EP | disclosed |
| US-12453708-B2 | Aminonaphthoquinone compounds for treatment and/or prevention of fibrosis diseases | CALGENT BIOTECHNOLOGY CO., LTD. (TW) | 2025-10-28 | — | — | US | disclosed |
| EP-0149537-B1 | PROCESS FOR THE SYNTHESIS OF AMINONITROPYRIDINES | ELI LILLY AND COMPANY (US) | 1988-07-13 | — | — | EP | disclosed |
| US-4552967-A | Process for the synthesis of intermediates in the preparation of diaminopyridines | ELI LILLY AND COMPANY (US) | 1985-11-12 | — | — | US | disclosed |
| EP-0149537-A2 | Process for the synthesis of aminonitropyridines | ELI LILLY AND COMPANY (US) | 1985-07-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12453708-B2 | Aminonaphthoquinone compounds for treatment and/or prevention of fibrosis diseases | KEAP1, GOT2, COL1A1 | ALDH1A1 106/4885MAPT 3640/4885TDP1 1161/4885 |
| US-20260116878-A1 | INDAZOLE INHIBITORS OF THE WNT SIGNAL PATHWAY AND THERAPEUTIC USES THEREOF | WNT1, WNT3, WNT3A | ALDH1A1 1879/4885MAPT 1206/4885TDP1 3553/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.